Return On Equity of Lineage Cell Therapeutics, Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Lineage Cell Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Lineage Cell Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -122%, a 300% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. annual Return On Equity for 2024 was -27%, a 17% increase from 2023.
  • Lineage Cell Therapeutics, Inc. annual Return On Equity for 2023 was -32%, a 3.9% increase from 2022.
  • Lineage Cell Therapeutics, Inc. annual Return On Equity for 2022 was -33%, a 13% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Lineage Cell Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -122% -91% -300% 01 Jul 2025 30 Sep 2025
Q2 2025 -61% -25% -69% 01 Apr 2025 30 Jun 2025
Q1 2025 -23% +12% +35% 01 Jan 2025 31 Mar 2025
Q4 2024 -27% +5.3% +17% 01 Oct 2024 31 Dec 2024
Q3 2024 -30% +2.7% +8.1% 01 Jul 2024 30 Sep 2024
Q2 2024 -36% -5.9% -19% 01 Apr 2024 30 Jun 2024
Q1 2024 -35% -3.5% -11% 01 Jan 2024 31 Mar 2024
Q4 2023 -32% +1.3% +3.9% 01 Oct 2023 31 Dec 2023
Q3 2023 -33% +25% +43% 01 Jul 2023 30 Sep 2023
Q2 2023 -30% +23% +43% 01 Apr 2023 30 Jun 2023
Q1 2023 -31% +15% +32% 01 Jan 2023 31 Mar 2023
Q4 2022 -33% +5% +13% 01 Oct 2022 31 Dec 2022
Q3 2022 -58% -48% -453% 01 Jul 2022 30 Sep 2022
Q2 2022 -54% -43% -379% 01 Apr 2022 30 Jun 2022
Q1 2022 -46% -33% -240% 01 Jan 2022 31 Mar 2022
Q4 2021 -38% -17% -79% 01 Oct 2021 31 Dec 2021
Q3 2021 -11% +16% +61% 01 Jul 2021 30 Sep 2021
Q2 2021 -11% +22% +66% 01 Apr 2021 30 Jun 2021
Q1 2021 -14% +38% +73% 01 Jan 2021 31 Mar 2021
Q4 2020 -21% -12% -136% 01 Oct 2020 31 Dec 2020
Q3 2020 -27% +15% +35% 01 Jul 2020 30 Sep 2020
Q2 2020 -33% -56% -249% 01 Apr 2020 30 Jun 2020
Q1 2020 -51% -94% -219% 01 Jan 2020 31 Mar 2020
Q4 2019 -9% +30% +77% 01 Oct 2019 31 Dec 2019
Q3 2019 -42% +12% +23% 01 Jul 2019 30 Sep 2019
Q2 2019 22% +109% 01 Apr 2019 30 Jun 2019
Q1 2019 43% +124% 01 Jan 2019 31 Mar 2019
Q4 2018 -39% -28% -264% 01 Oct 2018 31 Dec 2018
Q3 2018 -54% -81% -303% 01 Jul 2018 30 Sep 2018
Q2 2018 -86% -127% -315% 01 Apr 2018 30 Jun 2018
Q1 2018 -81% -154% -212% 01 Jan 2018 31 Mar 2018
Q4 2017 -11% -43% -134% 01 Oct 2017 31 Dec 2017
Q3 2017 27% -0.85% -3.1% 01 Jul 2017 30 Sep 2017
Q2 2017 40% +67% 01 Apr 2017 30 Jun 2017
Q1 2017 73% +155% 01 Jan 2017 31 Mar 2017
Q4 2016 32% +104% 01 Oct 2016 31 Dec 2016
Q3 2016 27% +99% 01 Jul 2016 30 Sep 2016
Q2 2016 -27% +42% +61% 01 Apr 2016 30 Jun 2016
Q1 2016 -82% -7.5% -10% 01 Jan 2016 31 Mar 2016
Q4 2015 -72% +3% +3.9% 01 Oct 2015 31 Dec 2015
Q3 2015 -72% +34% +32% 01 Jul 2015 30 Sep 2015
Q2 2015 -69% +47% +40% 01 Apr 2015 30 Jun 2015
Q1 2015 -75% +45% +38% 01 Jan 2015 31 Mar 2015
Q4 2014 -75% +58% +43% 02 Oct 2014 31 Dec 2014
Q3 2014 -105% +1.1% +1% 01 Jul 2014 30 Sep 2014
Q2 2014 -116% -27% -30% 01 Apr 2014 30 Jun 2014
Q1 2014 -120% -38% -46% 01 Jan 2014 31 Mar 2014
Q4 2013 -133% -64% -92% 29 Sep 2013 31 Dec 2013
Q3 2013 -106% -48% -82% 01 Jul 2013 30 Sep 2013
Q2 2013 -89% -40% -83% 01 Apr 2013 30 Jun 2013
Q1 2013 -82% -40% -96% 01 Jan 2013 31 Mar 2013
Q4 2012 -69% 01 Oct 2012 31 Dec 2012
Q3 2012 -58% 01 Jul 2012 30 Sep 2012
Q2 2012 -49% 01 Apr 2012 30 Jun 2012
Q1 2012 -42% 01 Jan 2012 31 Mar 2012

Lineage Cell Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -27% +5.3% +17% 01 Jan 2024 31 Dec 2024
2023 -32% +1.3% +3.9% 01 Jan 2023 31 Dec 2023
2022 -33% +5% +13% 01 Jan 2022 31 Dec 2022
2021 -38% -17% -79% 01 Jan 2021 31 Dec 2021
2020 -21% -12% -136% 01 Jan 2020 31 Dec 2020
2019 -9% +30% +77% 01 Jan 2019 31 Dec 2019
2018 -39% -28% -264% 01 Jan 2018 31 Dec 2018
2017 -11% -43% -134% 01 Jan 2017 31 Dec 2017
2016 32% +104% 01 Jan 2016 31 Dec 2016
2015 -72% +2.9% +3.8% 01 Jan 2015 31 Dec 2015
2014 -75% +58% +43% 01 Jan 2014 31 Dec 2014
2013 -133% -64% -92% 01 Jan 2013 31 Dec 2013
2012 -69% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.